Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
3.110
+0.040 (1.30%)
May 6, 2026, 2:03 PM EDT - Market open
ACTU's stock price has decreased by -70.32% in the past year and price targets may not have had time to catch up.

Actuate Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$17.50
Upside
+462.70%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+382.32%Apr 22, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$20$15
Strong BuyMaintains$20$15+382.32%Apr 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+543.09%Nov 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+543.09%Sep 23, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$20
Strong BuyInitiates$20+543.09%Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+543.09%Aug 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$20
Strong BuyInitiates$20+543.09%Mar 17, 2025